Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
07/19/1994 | US5330892 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans |
07/19/1994 | CA1330768C Monoclonal anti-human granulocyte colony stimulating factor antibody |
07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
07/13/1994 | EP0605789A1 Characterization of oncogenes and assays based thereon |
07/13/1994 | EP0605653A1 A new form of liposaccharide binding protein (lbp) |
07/13/1994 | EP0605635A1 Method to detect tumor necrosis factor (tnf) as bioactive form |
07/13/1994 | EP0605629A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
07/13/1994 | EP0605627A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
07/13/1994 | EP0605522A1 Production of chimeric antibodies - a combinatorial approach |
07/13/1994 | EP0605442A1 Recombinant antibodies for human therapy |
07/13/1994 | EP0579742A4 Product and method for improving keratinocyte adhesion to the dermis |
07/13/1994 | EP0563296A4 Optimization of binding proteins |
07/13/1994 | EP0341290B1 Immunoglobulin e competitor |
07/12/1994 | US5328991 Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
07/12/1994 | US5328988 Interleukin-7 |
07/12/1994 | US5328835 Expression of immunologically reactive HIV envelope proteins |
07/12/1994 | US5328834 Treating solution with soluble protease, complexing protease after inactivating it, separating the complex |
07/12/1994 | CA1330639C Lipid-protein compositions and articles and methods for their preparation |
07/07/1994 | WO1994015218A1 Detection of cystic fibrosis or a cftr gene mutation |
07/07/1994 | WO1994015217A1 Process for detecting heart muscle necroses using antibodies against n-terminal troponine i-peptide |
07/07/1994 | WO1994015028A1 Runway-maintenance device |
07/07/1994 | WO1994014975A1 Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same |
07/07/1994 | WO1994014974A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
07/07/1994 | WO1994014961A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
07/07/1994 | WO1994014960A2 Protocadherin, their autibodies and uses |
07/07/1994 | WO1994014846A1 Assay and treatment for demyelinating diseases such as multiple sclerosis |
07/07/1994 | WO1994014844A1 Bone resorption assay |
07/07/1994 | WO1994014475A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT |
07/07/1994 | WO1994014469A1 Multivalent ab1 antibodies as vaccines |
07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
07/07/1994 | WO1994014454A1 Vaccines against sterols |
07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
07/07/1994 | WO1994014347A1 A protective garment |
07/07/1994 | WO1994011523A3 Fully impaired consensus kozac sequences for mammalian expression |
07/07/1994 | WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity |
07/07/1994 | WO1994011508A3 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
07/07/1994 | WO1994011507A3 Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna |
07/07/1994 | WO1994011502A3 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
07/07/1994 | CA2127797A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
07/06/1994 | EP0604693A1 Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same |
07/06/1994 | EP0604647A1 Alleviation of symptoms associated with inflammatory disease states |
07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
07/06/1994 | EP0604603A1 Cadherin materials and methods |
07/06/1994 | EP0604584A1 Factors for the cellular functional regulation and biological applications thereof |
07/06/1994 | EP0604580A1 EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
07/06/1994 | EP0604560A1 Human cyclin e |
07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
07/06/1994 | EP0604453A1 Disease associated b-cell epitopes of tpo and use thereof |
07/06/1994 | EP0216854B1 Monoclonal antibodies and assay |
07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
07/05/1994 | US5326858 Genetic engineering; antiarthritic agents |
07/05/1994 | US5326857 ABO genotyping |
07/05/1994 | US5326779 Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles |
07/05/1994 | US5326778 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
07/01/1994 | CA2086577A1 Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene |
06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
06/29/1994 | EP0603672A2 Process for the production of recombinant and synthetic peptides and their use |
06/29/1994 | EP0603671A2 Process of reactivating purified membrane proteins |
06/29/1994 | EP0603307A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
06/29/1994 | EP0576476A4 Immunoassay for detection of mutant p53 polypeptide in biological fluids |
06/29/1994 | EP0564460A4 An augmented western blot format and immunoassay for detection of viral antibodies |
06/29/1994 | EP0563165A4 Reagents and kits for determination of fetal restricted antigens |
06/29/1994 | EP0444118B1 Pyruvate-kinase-isoenzyme-type-m2 (tumour m2-pk) specific antibodies, process for producing them and use |
06/29/1994 | EP0354923B1 Method for labelling antibodies with a metal ion |
06/29/1994 | CN1025219C Monoclonal antibody specific to HTV antigens |
06/28/1994 | US5324820 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
06/28/1994 | US5324663 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
06/28/1994 | US5324628 Use of chymotrypsin for the inactivation of prekallikrein activator |
06/28/1994 | US5324614 Toner image removal fixed onto support |
06/28/1994 | US5324511 Contain a single flagellar (H) antigen of serotype a or a combination with an antigen of serotype b; inhibit motility of pathogens |
06/28/1994 | US5324510 Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
06/24/1994 | CA2112193A1 Process for preparing recombinant and synthetic peptides, and their use |
06/24/1994 | CA2112192A1 Process for reactivating purified membrane proteins |
06/23/1994 | WO1994014072A1 Serum pyridinium crosslinks assay |
06/23/1994 | WO1994014070A1 Immunoassay for the measurement of collagen cleavage in cartilage |
06/23/1994 | WO1994014067A1 Diagnosis and therapy of sarcoidosis |
06/23/1994 | WO1994013836A1 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
06/23/1994 | WO1994013815A1 Dna encoding chitin deacetylase |
06/23/1994 | WO1994013806A1 Multivalent single chain antibodies |
06/23/1994 | WO1994013805A1 Humanised antibodies directed against a33 antigen |
06/23/1994 | WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use |
06/23/1994 | WO1994013802A1 D4 gene and methods of use thereof |
06/23/1994 | WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
06/23/1994 | WO1994013794A1 Human thrombospondin-4 |
06/23/1994 | WO1994013701A2 Delta-like gene expressed in neuroendocrine tumors |
06/23/1994 | WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
06/23/1994 | WO1994013699A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
06/23/1994 | WO1994013322A1 Improved synthesis of polymer bio-active conjugates |
06/23/1994 | WO1994013315A1 A novel eukaryotic transcription protein: host cell factor |
06/23/1994 | WO1994013307A1 Platelet activation and function |
06/23/1994 | WO1994013264A1 Clostridial toxin disease therapy |
06/23/1994 | WO1994013253A1 Hair dye or cosmetic material, pretreatment agent and hair dyeing method |
06/23/1994 | WO1994012536A1 A petroleum immunoassay method, its components and a kit for use in performing the same |
06/23/1994 | CA2151455A1 Delta-like gene expressed in neuroendocrine tumors |